Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 9Breast Neoplasms 6Neoplasms 4Colorectal Neoplasms 3Multiple Myeloma 2Insulin Resistance 2Cardiotoxicity 2Weight Loss 1Warts 1Skin Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Ovarian Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Melanoma 1Lymphoma 1Limb-girdle muscular dystrophy, type 2C 1Leukemia, Myeloid, Acute 1Hematologic Neoplasms 1Fatigue 1Diabetes Mellitus, Type 2 1Diabetes Mellitus 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Cachexia 1Brenner Tumor 1Bone Metastases 1Body Weight 1

Interventions

Memantine 2acetaminophen, aspirin, caffeine drug combination 1Transcranial Direct Current Stimulation 1Time 1Sugars 1Sirolimus 1Riluzole 1Referral and Consultation 1Ramipril 1Radiotherapy, Intensity-Modulated 1Palliative Care 1Ibuprofen 1Exercise 1Donepezil 1Cognitive Behavioral Therapy 1Cannabidiol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Cognitive Dysfunction × Exercise × Clear all
NCT02332876 2018-07-11

Physical Activity and Neuropsychological Outcomes in a Cancer Population

University of California, San Diego

Phase NA Completed
87 enrolled 7 charts

Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡